Helps maintain cardiovascular health Stay Energized at the Cellular Level As we age, our natural production of carnitine declines, which can hinder cellular energy generation
The most commonly reported adverse effects are gastrointestinal in nature, including nausea, diarrhea, vomiting, constipation, and abdominal pain
A reduction in carnitine levels may occur as a result of the treatment for these conditions, but more studies are needed to confirm the results
Some notice reduced appetite within the first week
By July 31, 2025, the FDA had received 605 reports of adverse events linked to compounded semaglutide and 545 reports for compounded tirzepatide
That number is nearly double the amount reported in 2022